Director Edward Wholihan receives 3,472 KRMD shares in Form 4 award

Rhea-AI Filing Summary

KORU Medical Systems director Edward Wholihan received an award of 3,472 shares of Common Stock of KORU Medical Systems, Inc. The shares were granted at a price of $4.32 per share and are reported as directly owned.

Following this grant, Wholihan now directly holds 47,741 shares of Common Stock. This was recorded as a grant, award, or other acquisition on a Form 4 insider transaction report, rather than an open-market purchase or sale.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider WHOLIHAN EDWARD

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	3,472	$4.32	$15K

Holdings After Transaction: Common Stock — 47,741 shares (Direct)

Footnotes (1)

Key Figures

Shares awarded: 3,472 shares Grant price: $4.32 per share Shares held after award: 47,741 shares

3 metrics

Shares awarded 3,472 shares Common Stock grant on Form 4

Grant price $4.32 per share Price per share for awarded Common Stock

Shares held after award 47,741 shares Direct ownership following the transaction

Key Terms

Common Stock, Grant, award, or other acquisition, Form 4

3 terms

Common Stock financial

"security_title: "Common Stock""

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

Grant, award, or other acquisition financial

"transaction_code_description: "Grant, award, or other acquisition""

Form 4 regulatory

"INSIDER FILING DATA (Form 4):"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

WHOLIHAN EDWARD

(Last) (First) (Middle)

C/O KORU MEDICAL SYSTEMS, INC.

100 CORPORATE DRIVE

(Street)

MAHWAH NEW JERSEY 07430

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
KORU Medical Systems, Inc. [ KRMD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	04/01/2026		A		3,472	A	$4.32	47,741	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

The filing of this statement shall not be construed as an admission (a) that the person filing this statement is, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the beneficial owner of any equity securities covered by this statement, or (b) that this statement is legally required to be filed by such person. Power of Attorney has been previously filed.

	/s/ Thomas Adams - Attorney-in-Fact	04/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did KRMD director Edward Wholihan report on this Form 4?

Edward Wholihan reported receiving an award of 3,472 shares of KORU Medical Systems Common Stock. The transaction is coded as a grant, award, or other acquisition, meaning these shares were not bought in the open market but granted to him directly.

How many KRMD shares did Edward Wholihan acquire and at what price?

Edward Wholihan acquired 3,472 shares of KORU Medical Systems Common Stock at $4.32 per share. The filing classifies this as a grant or award transaction, not a market trade, and it increases his directly held share position in the company.

How many KORU Medical Systems (KRMD) shares does Edward Wholihan hold after this grant?

After the 3,472-share award, Edward Wholihan directly holds 47,741 shares of KORU Medical Systems Common Stock. This post-transaction holding figure comes directly from the Form 4, which shows his ownership following the reported acquisition.

Was Edward Wholihan’s KRMD transaction a market purchase or a share award?

The transaction was a share award, not a market purchase. It carries code A, described as a grant, award, or other acquisition, and records 3,472 shares of Common Stock being acquired directly rather than through buying or selling on the open market.

Does this KRMD Form 4 show any share sales by Edward Wholihan?

The Form 4 shows no share sales by Edward Wholihan. It reports only one transaction coded as an acquisition via grant or award of 3,472 Common Stock shares, increasing his directly held position to a total of 47,741 shares after the transaction.